Efficacy and safety of body skincare product containing Levan

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200919001

Enrollment

Registered

2020-09-19

Start date

2020-09-25

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer Healthy Volunteer

Interventions

Cream&#45

base&#44

Apply product on forearm 1.5g twice a day after bath.Duration 7 days.,Skin care product containing Levan(1 mg/ml)&#44

Apply product on forearm 1.5g twice a day after bath.Duration 7 days

Active Comparator Drug,Experimental Drug

base,Cream&#45

base containing Levan

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. No history of allergic reaction to any skin care products. 2. No skin lesions including inflammation, infection, trauma and tumors 3. Not pregnant and breastfeeding

Exclusion criteria

Exclusion criteria: 1. When there is an adverse reaction from using the product 2. Volunteer cannot complete the experiment. 3 The number of times that skin care product are applied less than 80%. 4. Apply skin care products in the wrong protocol

Design outcomes

Primary

Measure	Time frame
Skin hydration 7 days Corneometer CM825,Transepidermal water loss 7 days Tewameter TM300	—

Secondary

Measure	Time frame
Adverse effect 7 days questionnaire	—

Countries

Thailand

Contacts

Public ContactApiradee Vararungzarit

Faculty of medicine, Burapha University

nphonja@gmail.com0815775779

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026